Sensorion Receives Approval from the UK Drug Agency to Initiate Clinical Trial of SENS-218

Read

Positive results obtained in phase 1b of the clinical study on SENS-111 and setting up of additional funding

Read

Sensorion has presented an abstract on recovering hearing loss at the Neuroscience 2015 annual meeting in Chicago

Read

First-half results in line with the Company’s buoyant development

Read

Sensorion successfully closes an €8 million international private placement to accelerate its development strategy

Read

Next events